Meeting
2024 ASCO Gastrointestinal Cancers Symposium
Genomic characterization of cholangiocarcinoma with autoimmune etiologies.
Authors
Xin Wang
Princess Margaret Cancer Centre, Toronto, ON, Canada
Xin Wang , Oumaima Hamza , Michelle Chan-Seng-Yue , Amy Zhang , Gun Ho Jang , Ayelet Borgida , Manny Kapur , Anna Dodd , Roxana Bucur , Julie Wilson , Arndt Vogel , Steven Gallinger , Faiyaz Notta , Grainne M. O'Kane , Gonzalo Sapisochin , Jennifer J. Knox , Robert C. Grant
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer
Sub Track
Translational Research
Citation
J Clin Oncol 42, 2024 (suppl 3; abstr 531)
DOI
10.1200/JCO.2024.42.3_suppl.531
Abstract #
531
Poster Bd #
E18
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Alteration of gut microbiota composition in patients with cholangiocarcinoma with non-responsiveness to first-line chemotherapy: A pilot study.
First Author: Thanika Ketpueak
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Cost-effectiveness of gemcitabine plus cisplatin with and without durvalumab in patients with advanced cholangiocarcinoma.
First Author: J. Alberto Maldonado
Poster
2024 ASCO Annual Meeting
Safety of pressurized intraperitoneal aerosolized chemotherapy (PIPAC) in patients (pts) with biliary tract cancer with peritoneal metastases.
First Author: Daneng Li
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Real-world testing, treatment patterns, and outcomes following liquid biopsy in advanced cholangiocarcinoma.
First Author: Amit Mahipal